Dr. Nataliya Melnyk, MD

  • Bel Air, MD
  • Hematologist and oncologist
NPI1023306065PAC ID6709008105
Medicare services, 2024
31,673
Medicare patients, 2024
499
Part D claims, 2024
644
Hospital affiliations
2
Industry payments
$1,722
Practice address
500 Upper Chesapeake Drive, Bel Air, MD 21014
Practice phone
Call (443) 643-3303
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Find Dr. Melnyk's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Nataliya Melnyk is a hematologist and oncologist in Bel Air, Maryland

Dr. Melnyk practices at University of Maryland Upper Chesapeake Medical Center Bel Air in Bel Air, Maryland, part of University of Maryland Medical System.

Dr. Melnyk's NPI, 1023306065, was assigned on July 12, 2011. Dr. Melnyk holds Maryland license D91920.

NPI and contact details
Medicare PAC ID
6709008105
NPI enumeration date
July 12, 2011
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(443) 643-3303
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
50
Medical school graduation
2002

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Nataliya Melnyk practices at University of Maryland Upper Chesapeake Medical Center Bel Air in Bel Air, Maryland

Dr. Melnyk's primary practice is University of Maryland Upper Chesapeake Medical Center Bel Air, at 500 Upper Chesapeake Drive, Bel Air, MD 21014 in Harford County. The practice phone is (443) 643-3303.

Source: Dmand AI Affiliation Data

Dr. Nataliya Melnyk is affiliated with 2 sites of care and 2 medical groups

Dr. Melnyk's primary practice is University of Maryland Upper Chesapeake Medical Center Bel Air in Bel Air, Maryland, part of University of Maryland Medical System. Dr. Melnyk is also affiliated with University of Maryland Medical Center. The medical group on file is Agape Physical Therapy. Dmand AI also links Dr. Melnyk to 1 more medical group, named with a free account.

See all 4 affiliations for Dr. Melnyk

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Nataliya Melnyk's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Melnyk practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
University of Maryland Upper Chesapeake Medical Center Bel AirAvailable with a free account
+1 more site and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Melnyk practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across University of Maryland Medical System and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Nataliya Melnyk is one of 245 hematologists and oncologists in Maryland

Hematology and oncology is Dr. Melnyk's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Melnyk is board certified in hematology by the American Board of Internal Medicine. Dr. Melnyk is licensed in Maryland.

Specialties and state licenses

  • Hematology and oncology, MarylandPrimaryLicense D91920 · taxonomy 207RH0003X

Hematologists and oncologists near Dr. Melnyk

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Nataliya Melnyk billed Medicare for 31,673 services in 2024

CMS data shows 31,673 Medicare services from Dr. Melnyk across 22 procedure codes in 2024, for 499 Medicare patients. Medicare paid $1,436,500 for them.

Medicare services, 202431,673
Medicare patients499
Paid by Medicare$1.4M
Procedure codes22

Dr. Melnyk's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Drugs given in the office
2023: 02024: 28,844
Office and hospital visits
2023: 9932024: 1,0576%
Lab and pathology
2023: 5722024: 85850%
Tests and treatments
2023: 2442024: 644164%
Surgery
2023: 2602024: 2704%

Where Dr. Melnyk's Medicare services took place, 2024

  • In an office31,47799%
  • In a facility1961%

Dr. Melnyk compared with the Maryland median for hematologists and oncologists, 2024

  • Dr. Melnyk
  • Maryland median
Medicare services
31,673vs 1,88416.8 times
Medicare patients
499vs 39626% above
Part D claims
391vs 383Close to median

Medians across 205 hematologists and oncologists in Maryland with Dmand AI profiles that report each measure.

Dr. Melnyk's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Melnyk

Need commercial claims for Dr. Melnyk?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Melnyk and other hematologists and oncologists in Maryland.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Nataliya Melnyk treated 499 Medicare patients in 2024, average age 74

CMS counts 499 Medicare patients who saw Dr. Melnyk in 2024. The largest group is 75 to 84, with 204 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Melnyk's median patient age at 74, with 60% women.

Medicare patients, 2024499
Average age74
Average risk score1.97
Also on Medicaid11%

Dr. Melnyk's Medicare patients by age, 2024

Dr. Melnyk's Medicare patients by sex, 2024

  • Women31864%
  • Men18136%

Chronic conditions among Dr. Melnyk's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Arthritis52%
  4. Cancer41%
  5. Diabetes38%
  6. Ischemic heart disease36%
  7. Chronic kidney disease34%
  8. Anxiety33%

Share of Medicare patients with each condition. A patient can have several.

Dr. Melnyk's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 74

Patient panel by sex, all payers

  • Women60%
  • Men39%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Nataliya Melnyk wrote 644 Medicare Part D claims in 2024

In 2024, Dr. Melnyk wrote 644 Medicare Part D claims for 188 patients. 78% of them were for generic drugs. CMS names the drug for 391 of them, across 15 drugs with 11 or more claims each, at $93,438 in total drug cost. In 2023, CMS named 393 claims across 16 drugs.

Part D claims, 2024644
Drugs named by CMS15
Total drug cost$93,438
Part D patients188

Dr. Melnyk's Part D claims by kind of drug, 2024

  • Generic502 claims78%
  • Brand-name and other142 claims22%

Dr. Melnyk's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Melnyk's Part D claims, 2024

  • Opioids9%59 of 644 claims
  • Antibiotics4%24 of 644 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 3932024: 3911%

Drugs named by CMS: 15 in 2024, 16 in 2023.

See all prescribing by Dr. Melnyk

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Nataliya Melnyk offers telehealth to Medicare patients

Dr. Melnyk accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Melnyk as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Melnyk by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Nataliya Melnyk received $1,722 in industry payments from 2016 to 2025

CMS Open Payments shows 81 general payments to Dr. Melnyk from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Bristol-Myers Squibb Company paid the most, $312.

General payments to Dr. Melnyk by program year, 2016 to 2025

General payments to Dr. Melnyk by kind, 2016 to 2025

$1.7Kin total
  • Food and beverage$1,61194%
  • Education$1116%

Companies that paid Dr. Melnyk the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Melnyk

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Nataliya Melnyk is board certified in hematology

  1. Board certified in hematologyAmerican Board of Internal Medicine
  2. Board certified in medical oncologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Nataliya Melnyk's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Nataliya Melnyk

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Nataliya Melnyk's NPI number?

Dr. Nataliya Melnyk's NPI number is 1023306065. It was assigned on July 12, 2011, and it is active in the NPI Registry.

What kind of doctor is Dr. Nataliya Melnyk?

Dr. Nataliya Melnyk is a hematologist and oncologist in Bel Air, Maryland. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Nataliya Melnyk practice?

Dr. Melnyk practices at 500 Upper Chesapeake Drive, Bel Air, MD 21014. Dr. Melnyk's primary practice is University of Maryland Upper Chesapeake Medical Center Bel Air in Bel Air, Maryland, part of University of Maryland Medical System. Dmand AI also links Dr. Melnyk to 1 medical group.

What is Dr. Nataliya Melnyk's office phone number?

The practice phone on file for Dr. Melnyk is (443) 643-3303.

What is Dr. Nataliya Melnyk's medical license number?

Dr. Melnyk holds Maryland license D91920.

Which hospitals is Dr. Nataliya Melnyk affiliated with?

Dr. Melnyk practices at University of Maryland Upper Chesapeake Medical Center Bel Air in Bel Air, Maryland. Dr. Melnyk is also affiliated with University of Maryland Medical Center.

What medical group is Dr. Nataliya Melnyk part of?

Dr. Melnyk is linked to Agape Physical Therapy. Dmand AI links Dr. Melnyk to 1 more medical group.

Does Dr. Nataliya Melnyk accept Medicare?

Yes. CMS data shows Dr. Melnyk billed Medicare for 31,673 services in 2024, and Dr. Melnyk accepts Medicare assignment.

Does Dr. Nataliya Melnyk offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Melnyk as offering telehealth services.

How many Medicare patients does Dr. Nataliya Melnyk see?

CMS counts 499 Medicare patients who saw Dr. Melnyk in 2024, with an average age of 74.

Show 5 more questionsShow fewer questions

Is Dr. Nataliya Melnyk board certified?

Yes. Dr. Melnyk is board certified in hematology by the American Board of Internal Medicine.

What services does Dr. Nataliya Melnyk bill to Medicare?

In 2024, Dr. Melnyk's most billed Medicare services were injected or infused drug (J9271), office visit, established patient (99214) and lab and pathology test (85025).

What drugs does Dr. Nataliya Melnyk prescribe most?

In 2024 Medicare Part D data, Dr. Melnyk's most prescribed drugs by claims were Letrozole, Ondansetron HCl and Xarelto.

Has Dr. Nataliya Melnyk received payments from drug or device companies?

CMS Open Payments shows $1,722 in general payments to Dr. Melnyk from 24 companies from 2016 to 2025. The largest total came from Bristol-Myers Squibb Company.

How long has Dr. Nataliya Melnyk been practicing?

Dr. Melnyk graduated from medical school in 2002, 24 years ago.

Selling to hematology and oncology practices?

See hematologists and oncologists in Maryland by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)